311 related articles for article (PubMed ID: 23742995)
1. A novel method for evaluating natural and vaccine induced serological responses to Bordetella pertussis antigens.
Berbers GA; van de Wetering MS; van Gageldonk PG; Schellekens JF; Versteegh FG; Teunis PF
Vaccine; 2013 Aug; 31(36):3732-8. PubMed ID: 23742995
[TBL] [Abstract][Full Text] [Related]
2. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.
Cherry JD; Gornbein J; Heininger U; Stehr K
Vaccine; 1998 Dec; 16(20):1901-6. PubMed ID: 9796041
[TBL] [Abstract][Full Text] [Related]
3. Long-term immunogenicity of a single dose of acellular pertussis vaccine in paediatric health-care workers.
Littmann M; Hülsse C; Riffelmann M; Wirsing von König CH
Vaccine; 2008 May; 26(19):2344-9. PubMed ID: 18396360
[TBL] [Abstract][Full Text] [Related]
4. Determination of pertactin IgG antibodies for the diagnosis of pertussis.
Trollfors B; Lagergård T; Gunnarsson E; Taranger J
Clin Microbiol Infect; 2003 Jul; 9(7):585-9. PubMed ID: 12925096
[TBL] [Abstract][Full Text] [Related]
5. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
[TBL] [Abstract][Full Text] [Related]
6. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
[TBL] [Abstract][Full Text] [Related]
7. Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis.
Cherry JD; Heininger U; Richards DM; Storsaeter J; Gustafsson L; Ljungman M; Hallander HO
Clin Vaccine Immunol; 2010 May; 17(5):741-7. PubMed ID: 20335431
[TBL] [Abstract][Full Text] [Related]
8. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.
Dalby T; Petersen JW; Harboe ZB; Krogfelt KA
J Med Microbiol; 2010 Sep; 59(Pt 9):1029-1036. PubMed ID: 20508003
[TBL] [Abstract][Full Text] [Related]
9. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
Winsnes R; Lønnes T; Møgster B; Berdal BP
Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
[TBL] [Abstract][Full Text] [Related]
10. Antibody Specificity Following a Recent
Raeven RHM; van der Maas L; Pennings JLA; Fuursted K; Jørgensen CS; van Riet E; Metz B; Kersten GFA; Dalby T
Front Immunol; 2019; 10():1364. PubMed ID: 31275314
[No Abstract] [Full Text] [Related]
11. Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children.
Hendrikx LH; Schure RM; Oztürk K; de Rond LG; de Greeff SC; Sanders EA; Berbers GA; Buisman AM
Vaccine; 2011 Sep; 29(40):6874-80. PubMed ID: 21803088
[TBL] [Abstract][Full Text] [Related]
12. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
Thomas MG; Ashworth LA; Miller E; Lambert HP
J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651
[TBL] [Abstract][Full Text] [Related]
13. Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis.
Isacson J; Trollfors B; Hedvall G; Taranger J; Zackrisson G
Scand J Infect Dis; 1995; 27(3):273-7. PubMed ID: 8539553
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of a three-component acellular pertussis vaccine administered at birth.
Belloni C; De Silvestri A; Tinelli C; Avanzini MA; Marconi M; Strano F; Rondini G; Chirico G
Pediatrics; 2003 May; 111(5 Pt 1):1042-5. PubMed ID: 12728086
[TBL] [Abstract][Full Text] [Related]
15. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.
Ausiello CM; Urbani F; La Sala A; Lande R; Piscitelli A; Cassone A
Dev Biol Stand; 1997; 89():315-20. PubMed ID: 9272365
[TBL] [Abstract][Full Text] [Related]
16. Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory.
Stenger RM; Smits M; Kuipers B; van Gaans-van den Brink J; Poelen M; Boog CJ; van Els CA
Vaccine; 2010 Sep; 28(40):6637-46. PubMed ID: 20637762
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 13 acellular pertussis vaccines: overview and serologic response.
Edwards KM; Meade BD; Decker MD; Reed GF; Rennels MB; Steinhoff MC; Anderson EL; Englund JA; Pichichero ME; Deloria MA
Pediatrics; 1995 Sep; 96(3 Pt 2):548-57. PubMed ID: 7659475
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children.
Podda A; Carapella De Luca E; Titone L; Casadei AM; Cascio A; Bartalini M; Volpini G; Peppoloni S; Marsili I; Nencioni L
J Pediatr; 1993 Jul; 123(1):81-4. PubMed ID: 8320630
[TBL] [Abstract][Full Text] [Related]
19. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.
Storsaeter J; Hallander HO; Gustafsson L; Olin P
Vaccine; 1998 Dec; 16(20):1907-16. PubMed ID: 9796042
[TBL] [Abstract][Full Text] [Related]
20. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.
Hendrikx LH; Berbers GA; Veenhoven RH; Sanders EA; Buisman AM
Vaccine; 2009 Nov; 27(47):6530-6. PubMed ID: 19729085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
